JIA-Associated Uveitis in Adults - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

JIA-Associated Uveitis in Adults

  • By

  • Alissa Belzie, MD, MS

  • Ana M. Suelves, MD, PhD

  • September 1, 2026

  • 13 min

Share

JIA-Associated Uveitis in Adults

Overview

Juvenile idiopathic arthritis-associated uveitis (JIAU) persists into adulthood, often leading to ongoing inflammation and ocular complications. A significant proportion of adults with JIAU continue to experience active disease and visual impairment.

Background

JIAU is the most common systemic disease-associated uveitis in childhood, contributing to ocular morbidity and vision loss. Many patients transition into adulthood with persistent inflammation and complications from prior treatments. Understanding the adult phenotype of JIAU is crucial for effective management.

Data Highlights

FindingPercentage
Ongoing inflammation in adults with JIAU52%
Patients with ocular complications46%
Cataract occurrence24%
Glaucoma occurrence20%
Visual acuity of 20/50 or worse28%
Visual acuity of 20/200 or worse15%

Key Findings

  • 52% of adults with JIAU had ongoing inflammation at their final visit.
  • 46% of patients developed ocular complications, including cataracts and glaucoma.
  • 28% of eyes had a visual acuity of 20/50 or worse.
  • Complications such as posterior synechiae and hypotony were independent predictors of persistent inflammation.
  • Long-term follow-up shows a pooled incidence of severe visual impairment at 16.6% after 18 years.

Clinical Implications

Ophthalmologists should be aware that JIAU can persist into adulthood, necessitating ongoing monitoring and management.

Conclusion

The persistence of JIAU into adulthood poses significant challenges for patient management.

Related Resources & Content

  1. Oray et al., 2023 -- JIA-Associated Uveitis in Adults
  2. MDSpire News — Is JIA-Related Uveitis Declining?
  3. Retinal Physician — UVEITIS CORNER: Current Management of Pediatric Uveitis
  4. the ophthalmologist — Rethinking Uveitis
  5. retinal physician — UVEITIS CORNER
  6. Is JIA-Related Uveitis Declining?
  7. Current Management of Pediatric Uveitis
  8. Rethinking Uveitis
  9. ACR Releases Updated Juvenile Idiopathic Arthritis Guidelines
  10. Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
  11. Glucagon-Like Peptide-1 Receptor Agonists and Risk of Uveitis | Diabetes | JAMA Ophthalmology | JAMA Network

Original Source(s)

Related Content